Bayer Faces Revenue Decline Amid Ongoing Glyphosate LitigationFri 6th Mar, 2026The pharmaceutical and agrochemical company Bayer continues to face significant financial and legal challenges, primarily due to ongoing litigation related to the glyphosate-based herbicide, Roundup. Bayer reported a net loss of approximately 3.6 billion euros for the year 2025, representing an increase of around 1.1 billion euros compared to the previous year. The settlement outlines payments of up to 7.25 billion US dollars (about 6.23 billion euros) over a period of up to 21 years. Total revenue declined by 2.2 percent, falling to 45.6 billion euros. The overall financial performance reflects the continued impact of both market conditions and the ongoing legal uncertainties surrounding glyphosate.

Source: The Munich Eye March 06, 2026 22:12 UTC